United States · FDA National Drug Code directory
DOXEPIN HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2557_7ddbac07-caff-42db-8b93-d9ac99bb4f3e
- Product NDC
- 71335-2557
- Form
- CAPSULE
- Composition / generic term
- DOXEPIN HYDROCHLORIDE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210423
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71335-2557-1) · 71335-2557-1
- 60 CAPSULE in 1 BOTTLE (71335-2557-2) · 71335-2557-2
- 28 CAPSULE in 1 BOTTLE (71335-2557-3) · 71335-2557-3
- 18 CAPSULE in 1 BOTTLE (71335-2557-4) · 71335-2557-4
- 90 CAPSULE in 1 BOTTLE (71335-2557-5) · 71335-2557-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →